Pathomorphological and histological prognostic factors in curatively resected ductal adenocarcinoma of the pancreas
- PMID: 10930222
- DOI: 10.1007/s005950070096
Pathomorphological and histological prognostic factors in curatively resected ductal adenocarcinoma of the pancreas
Abstract
The fate of patients with potentially resectable carcinomas is not only determined by the pTNM tumor stage, but also possibly by tumor-biological factors. The aim of this study was to identify these prognostic factors in patients undergoing primary curative (R0) resection. The study retrospectively analyzed 113 patients with ductal adenocarcinoma who were operated on between 1986 and 1995. R0 resection was able to be performed in 93 patients. Lymph node metastases were found in 73%. The rates of lymph vessel and perineural invasion were 83.5% and 45%, respectively. Among the 25 carcinomas without lymph node metastases, 64% already had lymph vessel invasion and 48% had perineural invasion. The cumulative 5-year survival rate of the 91 surviving patients analyzed was 10.5%. Depending on the tumor stage we found a significant difference in 5-year survival rates between patients without lymph node metastases (26.5%) and those with lymph node involvement (5%) (P = 0.008). A multivariate analysis only identified lymph vessel invasion (L0/1), tumor size (< or = or < or =2 cm), and tumor grading (G) to have significant and independent prognostic value. Lymph vessel invasion, tumor size, and tumor grading proved to be independent factors determining long-term prognosis.
Similar articles
-
Prognostic factors in the operative treatment of ductal pancreatic carcinoma.Langenbecks Arch Surg. 2000 Jan;385(1):14-20. doi: 10.1007/s004230050004. Langenbecks Arch Surg. 2000. PMID: 10664114
-
Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma.Eur J Surg Oncol. 2012 Apr;38(4):333-9. doi: 10.1016/j.ejso.2011.12.020. Epub 2012 Feb 7. Eur J Surg Oncol. 2012. PMID: 22317758
-
Adenocarcinoma of the pancreas: Does prognosis depend on mode of lymph node invasion?Eur J Surg Oncol. 2014 Nov;40(11):1578-85. doi: 10.1016/j.ejso.2014.04.012. Epub 2014 May 21. Eur J Surg Oncol. 2014. PMID: 24923739
-
Re-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreas.World J Gastroenterol. 2016 Jul 28;22(28):6424-33. doi: 10.3748/wjg.v22.i28.6424. World J Gastroenterol. 2016. PMID: 27605878 Free PMC article. Review.
-
Long-term survival after curative resection for pancreatic ductal adenocarcinoma--Surgical treatment.Int J Surg. 2015 Sep;21 Suppl 1:S1-3. doi: 10.1016/j.ijsu.2015.06.050. Epub 2015 Jun 26. Int J Surg. 2015. PMID: 26118618 Review.
Cited by
-
Current controversies and advances in the management of pancreatic adenocarcinoma.World J Gastrointest Oncol. 2021 Jun 15;13(6):472-494. doi: 10.4251/wjgo.v13.i6.472. World J Gastrointest Oncol. 2021. PMID: 34163568 Free PMC article. Review.
-
Clinical and pathological features of five-year survivors after pancreatectomy for pancreatic adenocarcinoma.World J Surg Oncol. 2014 Nov 27;12:360. doi: 10.1186/1477-7819-12-360. World J Surg Oncol. 2014. PMID: 25429841 Free PMC article.
-
Survival after surgical management of pancreatic adenocarcinoma: does curative and radical surgery truly exist?Langenbecks Arch Surg. 2005 Apr;390(2):94-103. doi: 10.1007/s00423-004-0476-9. Epub 2004 May 14. Langenbecks Arch Surg. 2005. PMID: 15578211 Review.
-
Usefulness of FDG PET/CT derived parameters in prediction of histopathological finding during the surgery in patients with pancreatic adenocarcinoma.PLoS One. 2019 Jan 10;14(1):e0210178. doi: 10.1371/journal.pone.0210178. eCollection 2019. PLoS One. 2019. PMID: 30629646 Free PMC article.
-
The incidence and survival rate of population-based pancreatic cancer patients: Shanghai Cancer Registry 2004-2009.PLoS One. 2013 Oct 9;8(10):e76052. doi: 10.1371/journal.pone.0076052. eCollection 2013. PLoS One. 2013. PMID: 24130758 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical